Introducing ResMed AirSenseTM11

ResMed AirSense 11 is a user-friendly CPAP machine that combines advanced technology with proven therapy modes1-3 designed for easy and quality sleep apnea therapy treatment.


AirSense 11 models

AirSense™ 11 AutoSet™

Auto-adjusting machine that changes airflow pressure levels on a breath-by-breath basis. It also includes the AutoSet for Her algorithm.

AirSense™ 11 Elite

Fixed pressure machine that delivers one consistent pressure.

Advanced therapy acclimation and support features

AirSense™ 11 is ResMed’s next generation of sleep apnea therapy, combining our proven1-3 algorithms and technologies with the latest digital innovations. Its sleek design compliments any bedroom and supports users in feeling more confident about their treatment. The desired result is a more comfortable and user-friendly experience for customers, designed to empower them to start with confidence, achieve therapy adherence and better clinical outcomes.

AirSense 11 highlights

AirSense 11 combines our proven1-3 therapy algorithms AutoSet™ and AutoSet™ for Her, with new digital support features such as our Personal Therapy Assistant, Test Drive in ResMed myAir™ and Care Check-In – where device set-up can be tailored to individual needs and customer progress can be monitored remotely via AirView ™.

Personal Therapy Assistant and Test Drive in myAir™

Whether set up remotely or in-person, Personal Therapy Assistant provides an interactive experience designed to help your customers start therapy with confidence and self-resolve common therapy issues. Available through ResMed’s patient engagement app, myAir™ , Personal Therapy Assistant offers voice-guided video setup instructions and Test Drive, a therapy acclimation tool designed to help users become more comfortable with using their AirSense 11 device. Empowering users to self-resolve common therapy issues may improve compliance and save you time with fewer troubleshooting calls and mask refits.

AS11 AirView_CareCheck-1920x1192-f49cd1b
Care Check-In

Support with starting CPAP therapy is built into ResMed AirSense™ 11 with the Care Check-In feature.

Time-based check-in questions are asked throughout the first 28 days of therapy, either through the myAir app‡ or directly on the device. Check-in questions are also asked every 6 months post-purchase. This provides users with an opportunity to provide feedback about their therapy progression. The Care Check-In responses deliver tailored coaching advice and support, encouraging users to stay on therapy and troubleshoot common therapy issues.

If users choose to opt in, data from their responses will be available to view in AirView™,* providing you with a deeper understanding of their therapy progress and an opportunity to address issues early in their therapy journey. 

Over-the-air updates

Automatic over-the-air updates ˄ ensure you and your customers benefit from future ResMed features and software upgrades on our AirSense 11 devices, so the latest technology is available always. 

Clinically proven algorithms2-4

AirSense 11 includes both the AutoSet and AutoSet for Her algorithms, which are among the most clinically published in the field of sleep-disordered breathing. It works to automatically adjust to each customer's therapy pressure as their needs change – hourly, nightly and from season to season – to deliver the customer’s ideal lowest therapy pressure.

Key features

  • Easy-to-use touchscreen makes navigating settings simple and intuitive.
  • Advanced event detection identifies central sleep apnea, respiratory effort–related arousal and Cheyne-Stokes respiration events to provide you with valuable insight into the continued health of your customers.
  • Using AirView, you can access nightly therapy data, troubleshoot (using the Remote Assist feature) and change device settings remotely. If users opt-in, data from their Care Check-In responses will be available in AirView, which can provide a deeper understanding of therapy progress.
  • AutoRamp™ with sleep onset detection delivers a low pressure to help users fall asleep with ease. Once the customer is asleep, it comfortably ramps up the pressure to the prescribed level. 
  • Expiratory pressure relief (EPR™) maintains the optimal treatment for the customer during inhalation and reduces pressure during exhalation.
  • AutoSet Response± comfort setting offers gentler pressure increases and a smoother night’s sleep to help customers with high-pressure intolerance.
  • Integrated heated humidifier can be controlled manually or automatically with the Climate Control feature.
  • Built-in ambient light sensor adjusts the brightness of the screen based on the light in the room and turns off automatically.
Supported by ResMed Air Solutions

ResMed Air Solutions is our ecosystem that includes AirSense 11, AirFit™ and AirTouch™ masks, and digital offerings such as ResMed AirView, our remote monitoring platform, and myAir, our patient engagement app. These work seamlessly together to support in delivering an optimised therapy experience for your customers and have been proven to help users acclimate and adhere to therapy.




Malhotra et al. “Patient engagement using new technology to improve adherence to positive airway pressure therapy: A retrospective analysis,” CHEST, 2018; 153(4):843-850. 


Massie CA et al. Comparison between automatic and fixed positive airway pressure therapy in the home. Am J Respir Crit Care Med 2003;167:20-23.


Netzel T et al. APAP device technology and correlation with patient compliance. Somnologie 2014;18(2):113-120.


Armistead JP et al. Study of an auto-adjusting CPAP algorithm for the treatment of obstructive sleep apnoea. Am J Respir Crit Care Med 2009;179:A3570.


AutoSet for Her algorithm is available in the AirSense 11 AutoSet device only.


‡ The myAir by ResMed app is available in English in Australia and New Zealand. 


* Care Check-In data is available in AirView upon customer consent.


˄ Over-the-air updates require cellular connectivity. Cellular connectivity depends on network availability.


± AutoSet response is available in the AirSense 11 AutoSet device only.  


†† Some features of ResMed myAir are only available in the myAir app.


** As defined by CMS criteria within the first 3 months of initial PAP therapy use: > 4 h/n, at least 70% of nights, during a consecutive 30-day period. 


≠ myAir requires cellular connectivity.


* Cellular connectivity depends on network availability